drugset / Trial / NCT03553342

Efficacy of Oral Corticosteroid Therapy in Recurrent Paralyzes After Thyroidectomy

NCT03553342 ↗

Phase 3 Unknown 156 enrolled Poitiers University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Thyroidectomy is a common surgical procedure in France. Recurrent paralysis is one of the main complications. Oral corticosteroid therapy are frequently used at a dosage of 1mg/kg for seven days, in case of recurrent paralysis to obtain remobilization as early as possible. The main objective is to evaluate the efficacy of oral corticosteroid therapy in remobilization of vocal cords at seven days in patients with unilateral recurrent paralysis after thyroidectomy.

Timeline

Start
2018-09-11
Primary completion
2021-09-11
Completion
2022-01-11

Outcome

Missed primary endpoint

paper oral corticosteroids do not enhance vocal cord remobilization or improve voice quality in patients with postoperative unilateral VFP. PMID 40773211 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Prednisolone Other / unclassified 1 mg/kg Oral